IL-13 Targeting Biologics for the Treatment of Atopic Dermatitis - Episode 9
Less Frequent Administration of Lebrikizumab for Atopic Dermatitis
Published on:
Panelists discuss the maintenance of treatment efficacy in the lebrikizumab clinical trial, highlighting data on sustained improvement in atopic dermatitis symptoms over time and the long-term effectiveness of the treatment.
Video content above is prompted by the following:
- Can you discuss maintenance of treatment efficacy in the lebrikizumab clinical trial?
